These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30746222)

  • 1. Choice of the surgical approach for patients with stage I lung squamous cell carcinoma ≤3 cm.
    Chen C; Wang Y; Pan X; Fu S; Shi Y; Yang J; Wang R
    J Thorac Dis; 2018 Dec; 10(12):6771-6782. PubMed ID: 30746222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis.
    Shao S; Song G; Wang Y; Yi T; Li S; Chen F; Li Y; Liu X; Han B; Liu Y
    Front Oncol; 2022; 12():946800. PubMed ID: 36081555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant treatment can improve prognosis in patients with non-small cell lung cancer ≤3 cm after sublobectomy: a propensity score analysis.
    Ma H; Cheng J; Yu Y; Liu B; Qin J; Xing W; Luo S
    J Thorac Dis; 2021 Jan; 13(1):312-321. PubMed ID: 33569211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.
    Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z
    J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobectomy Versus Sublobectomy in Stage IIIA/N2 Non-Small Cell Lung Cancer: A Population-Based Study.
    Wang S; Zhang Z; Gu Y; Lv X; Shi X; Liu M
    Front Oncol; 2021; 11():726811. PubMed ID: 34956862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
    Wu L; Zhao W; Chen T; Yang Y
    J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobectomy Versus Sublobectomy in Metachronous Second Primary Lung Cancer: A Propensity Score Study.
    Yang X; Zhan C; Li M; Huang Y; Zhao M; Yang X; Lin Z; Shi Y; Jiang W; Wang Q
    Ann Thorac Surg; 2018 Sep; 106(3):880-887. PubMed ID: 29852145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis analysis of lobectomy and sublobar resection in patients ≥75 years old with pathological stage I invasive lung adenocarcinoma of ≤3 cm: a propensity score matching-based analysis.
    Chen C; Ni Q; Shi Y; Fu S; Pan X; Wang Y; Yang J; Wang R
    Transl Cancer Res; 2019 Apr; 8(2):574-582. PubMed ID: 35116790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequate Number of Lymph Nodes Sampled May Determine Appropriate Surgical Modality for Early-Stage NSCLC: A Population-Based Real-World Study.
    Ling L; Zheng H; Lin H; Ge C; Li D; Wu L; Lou Y; Jiang T; Fu J
    Clin Lung Cancer; 2023 May; 24(3):e141-e151. PubMed ID: 36639280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
    Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
    Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital.
    Gao L; Shen L; Wang K; Lu S
    Lung Cancer; 2021 Dec; 162():54-60. PubMed ID: 34739854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
    Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
    J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of stage I NSCLC (≤3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis.
    Qu X; Wang K; Zhang T; Shen H; Dong W; Liu Q; Du J
    J Thorac Dis; 2017 Nov; 9(11):4561-4573. PubMed ID: 29268526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying optimal surgical approach among T1N2-3M0 non-small cell lung cancer patients: a population-based analysis.
    Ge T; Hu SQ; Ning J; Zhou YF; Bian DL; Teng MX; Chen LS; Yang J
    Transl Lung Cancer Res; 2024 Apr; 13(4):901-929. PubMed ID: 38736488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobectomy Can Improve the Survival of Patients With Non-small Cell Lung Cancer With Lung Oligometastatic.
    Wang L; Jiao F; Dong L; Li Q; Liu G; Hu X
    Front Surg; 2021; 8():685186. PubMed ID: 34291078
    [No Abstract]   [Full Text] [Related]  

  • 16. Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderly.
    Qiu C; Wang G; Xu J; Cui L; Dong W; Ni Y; Qu X; Du J
    Int J Surg; 2017 Jan; 37():1-7. PubMed ID: 27890654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer.
    Hao B; Zhang L; Fan T; Liu B; Jiang W; Hu H; Geng Q
    Front Oncol; 2020; 10():661. PubMed ID: 32500023
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching's Study.
    Zhang B; Liu R; Ren D; Li X; Wang Y; Huo H; Zhu S; Chen J; Song Z; Xu S
    Front Oncol; 2021; 11():610638. PubMed ID: 34026604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-lung cancer specific mortality after lobectomy or sublobectomy in patients with stage IA non-small cell lung cancer ≤2 cm: A propensity score analysis.
    Yin J; Zhao M; Lu T; Huang Y; Sui Q; Xi J; Lin Z; Xu S; Wang Q; Zhan C
    J Surg Oncol; 2019 Dec; 120(8):1486-1496. PubMed ID: 31602661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
    Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J
    J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.